Watch OACCU. Know when insiders buy.
One email the day a filing lands. Free.
OACCU
Oaktree Acquisition Corp. III Life Sciences
11.00
+0.00 +0.00%
USD · close Sep 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME $6.8M +38.8%NET CASH —52W 10.64 – 11.06SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$262K | $1.6M | −14.4% | — | −$97K | — | — | Aug 12 |
| Q1 2026 · Mar 31 | — | — | — | −$457K | $1.4M | −16.0% | — | −$158K | — | — | Aug 12 |
| Q4 2025 · Dec 31derived | — | — | — | −$255K | $1.8M | +29.7% | — | −$144K | — | — | Mar 26 |
| Q3 2025 · Sep 30 | — | — | — | −$226K | $2M | — | — | −$57K | — | — | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$270K | $1.9M | — | — | −$146K | — | — | Aug 12 |
| Q1 2025 · Mar 31 | — | — | — | −$445K | $1.7M | — | — | −$76K | — | — | Aug 12 |
| Q4 2024 · Dec 31derived | — | — | — | −$304K | $1.4M | — | — | −$90K | — | — | Mar 26 |
| Q3 2024 · Sep 30 | — | — | — | −$48K | −$48K | — | — | $0 | — | — | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$1.2M | $7.3M | — | — | −$422K | — | — | — | — |
Every number comes from Oaktree Acquisition Corp. III Life Sciences's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.